PIPERAZINE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Piperazine, and what generic alternatives are available?
Piperazine is a drug marketed by Alpharma Us Pharms, Lannett, Luitpold, and Impax Labs. and is included in four NDAs.
The generic ingredient in PIPERAZINE is piperazine citrate. There are eighteen drug master file entries for this compound. Additional details are available on the piperazine citrate profile page.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for PIPERAZINE?
- What are the global sales for PIPERAZINE?
- What is Average Wholesale Price for PIPERAZINE?
Summary for PIPERAZINE
| US Patents: | 0 |
| Applicants: | 4 |
| NDAs: | 4 |
| DailyMed Link: | PIPERAZINE at DailyMed |
US Patents and Regulatory Information for PIPERAZINE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Alpharma Us Pharms | PIPERAZINE CITRATE | piperazine citrate | SYRUP;ORAL | 080774-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Impax Labs | PIPERAZINE CITRATE | piperazine citrate | TABLET;ORAL | 080874-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Lannett | PIPERAZINE CITRATE | piperazine citrate | SYRUP;ORAL | 080963-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
